OnAudience

The supplied evidence does not contain any information about OnAudience. The only source provided is a press release about Debiopharm's antibody-drug conjugate linker research, which is unrelated to OnAudience and mentions no data, advertising, or audience business. As a result, this dossier cannot responsibly describe OnAudience's origin, products, ownership, headquarters, or market position. The entry is flagged for review so that a proper source (for example the brand's official website or a Wikipedia article) can be attached before the dossier is completed.

• 2026.10.14

  Reported2026.10.14

  OnAudience launches OnAudience MCP integration bringing audience data into AI assistant advertising workflows[2]OnAudience推出OnAudience MCP集成，将受众数据引入AI助手广告工作流adweek.com

  OnAudience announced the launch of OnAudience MCP, a Model Context Protocol integration that connects AI assistants directly to OnAudience's proprietary audience data and technology. The integration lets media planners create custom audience profiles, search more than 4,100 ready-made audience segments, explore audience insights and prepare campaigns for DSP activation within their AI assistant. The first integration is available through Claude, with plans to expand support to other AI assistants.

Read more

1. 1Debiopharm's Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistancefinanznachrichten.de
2. 2OnAudience推出OnAudience MCP集成，将受众数据引入AI助手广告工作流adweek.com